Loading company…
Shenzhen Force of Life Science is a drug developer focused on oncology, including tumor-targeted and immunomodulatory drugs.
Established in 2016 and based in Shenzhen, China, Shenzhen Force of Life Science Co., Ltd. develops targeted and immunotherapies for cancer, along with drugs for immunity and cardiac metabolic diseases. Its research arm, Touchstone Translational Research Institute, runs disease biology-driven drug discovery programs. Founder Yongkun Sun was previously vice president of Moshadong R&D (China) Co., Ltd., and CMO Johannes Nippgen was Head of R&D at Merck Pharma R&D, China. The company is listed at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Shenzhen Force of Life Science Co., Ltd.? This is my company